Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its Non-Addictive Analgesic is an engineering non-addictive analgesic peptide for pain management. Its Dual Gene Therapy targets type 2 diabetes and obesity. The Company’s subsidiary, PreveCeutical (Australia) Pty Ltd., manages its research programs.

CSE:PREV - Post by User

Preveceutical Medical Inc

Bullboard Posts

Comment by BonnieBrookson Nov 24, 2017 1:13pm

140 Views

Post# 27026408

RE:RE:RE:75 cent Fully Subcribed PP

Wonder what there using the cash that they raised for? how many time have you heard from VSE companies that “ proceeds are used for company operations “ the only operators that I’m aware of is a small suite in Vancouver

can an ant one enlightened me on where their research facilities are?

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading